ISIrina Yakovlevna Sokolova

Irina Yakovlevna Sokolova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irina Yakovlevna Sokolova has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Paroxysmal nocturnal hemoglobinuria: Diagnostic search in refractory anemia (case report)

    by N. V. Chichkova, M. D. Madoyan, A. D. Aga, I. Ya. Sokolova, N. V. Morozova, V. V. Fomin, Н. В. Чичкова, М. Д. Мадоян, А. Д. Ага, И. Я. Соколова, et al.

    Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal bone marrow disorder caused by a mutation in the PIG-A gene and a deficiency of GPI-anchor proteins on the surface of blood cells. The clinical picture is characterized by chronic intravascular hemolysis, cytopenias, and thrombotic complications. Diagnosis of PNH is often difficult due to the polymorphism of symptoms and the lack of pathognomonic features. This article presents a clinical observation of an 87-year-old patient with longstanding refractory anemia that was unresponsive to standard therapy with iron, vitamins B 9 and B 12 , and blood transfusions. Key laboratory markers that led to the suspicion of PNH included significantly elevated lactate dehydrogenase (LDH), indirect bilirubin, reticulocytosis, a negative direct Coombs test, decreased haptoglobin, and the detection of hemosiderinuria. After excluding myelodysplastic syndrome (MDS) and oncologic pathology, flow cytometry revealed a large PNH clone (86% granulocytes with FLAER/CD24 deficiency, 18% type Ill red blood cells). This clinical case demonstrates the importance of a targeted search for PNH in elderly patients with unexplained hemolysis.

  • Changes and prognostic relationships of markers of cardiotoxicity, endothelial dysfunction, inflammation, and left ventricular diastolic remodeling in patients with lymphomas over long-term monitoring

    by I. Ya. Sokolova, Sh. M. Murtuzaliev, P. A. Markin, S. A. Appolonova, T. Yu. Kulagina, O. A. Zhigulina, N. V. Khabarova, V. G. Varzieva, Yu. N. Belenkov, I. S. Ilgisonis

    Aim . To study the profile and long-term changes of recommended markers of cardiotoxicity (high-sensitivity troponin I (hs-TnI), N-terminal pro-brain natriuretic peptide (NT-proBNP)), markers of endothelial dysfunction (endothelin-1 (ET-1)), systemic inflammation (C-reactive protein (CRP), interleukin-6 (IL-6)) and left ventri­cular (LV) structural and functional characteristics in patients with lymphomas 12 months after the start of multiagent chemotherapy, as well as to evaluate the relationship between the obtained data. Material and methods . The study included patients with newly diagnosed lymphomas (n=30) as follows: 18 men (60%); mean age — 52 [36; 64] years. Hodgkin lymphoma was diagnosed in 8 patients (26,7%), non-Hodgkin lymphomas — in 22 (73,3%). All patients underwent an assessment of laboratory markers (hs-TnI, NT-proBNP, ET-1, CRP, IL-6) and LV structural and functional parameters using speckle tracking echocardiography at baseline and 12 months after the start of treatment. Results . After 12 months from the start of chemotherapy, no significant changes in the levels of hs-TnI and NT-proBNP were noted. A significant decrease in the le­vels of CRP and IL-6 was observed as follows: from 5,94 [2,98; 34,00] mg/L to 1,31 [0,85; 5,98] mg/L (p=0,002) and from 12,20 [9,95; 12,75] pg/ml to 5,87 [4,7; 7,04] pg/ml (p=0,05), respectively. A significant increase in the median ET-1 level was also noted as follows: 3,46 [2,39; 4,12] ng/ml initially and 11,26 [7,02; 15,5] ng/ml after 12 months (pConclusion . The obtained data suggest the development of diastolic dysfunction (DD) during the first year after the initiation of chemotherapy in patients with lymphomas. The identified relationship between ET-1 levels and diastolic dysfunction parameters allows us to consider ET-1 as a potential predictor of LV DD in these patients, necessitating their monitoring before and long-term after chemotherapy. In the context of the search for the most effective methods for preventing and predicting cardiovascular toxicity after antitumor therapy, it seems appropriate to further study the relationship between endothelial dysfunction, diastolic dysfunction, heart failure with preserved ejection fraction, and other long-term cardiovascular events in cancer patients after treatment.

  • Open Access

    Simultaneous tumors: ovarian cancer in a patient with multiple myeloma

    by Igor Yu. Gadaev, Irina V. Gadaeva, Kseniya A. Rossolovskaya, Olga V. Bochkarnikova, Irina Yakovlevna Sokolova, Россоловская Ксения Антоновна

    Multiple myeloma is the second most common hematological malignancy, accounting for approximately 1% and 10–15% of malignant tumors of the hematopoietic and lymphoid systems, respectively. Until recently, the diagnosis of multiple myeloma was inherently associated with unfavorable prognosis of overall survival. On the one hand, advanced diagnosis techniques and the development of new treatment approaches have led to the improved life expectancy and significant reduction of mortality of patients with multiple myeloma. On the other hand, the medical and research communities have encountered a previously unknown issue: the combination of multiple myeloma with other types of cancer. This combination sets a task of multidisciplinary approach in the diagnosis and requires development of patient management strategy and prognostic parameters of the outcome. Some researchers adhere to the theory of independent tumor appearance in patients suffering from multiple myeloma, while other authors suppose that multiple myeloma and secondary cancer virtually represent multiple primary malignant neoplasms. This article presents a clinical case of postmortem verification of ovarian cancer in a patient with recurrent multiple myeloma.

  • Study of proinflammatory markers, galectin-3 level, lipid metabolism parameters, cardiovascular status and their relationship in patients with lymphomas before antitumor therapy

    by I. Ya. Sokolova, S. A. Kardovskaya, E. Yu. Salakheeva, Yu. Yu. Kirichenko, E. A. Siderko, O. V. Bochkarnikova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis

  • Open Access

    Study of proinflammatory markers, galectin-3 level, lipid metabolism parameters, cardiovascular status and their relationship in patients with lymphomas before antitumor therapy

    by I. Ya. Sokolova, S. A. Kardovskaya, E. Yu. Salakheeva, Yu. Yu. Kirichenko, E. A. Siderko, O. V. Bochkarnikova, A. A. Shchendrygina, Yu. N. Belenkov, И. С. Ильгисонис, Ю. Ю. Кириченко

    Изучение провоспалительных маркеров, уровня галектина-3, параметров липидного обмена, сердечно-сосудистого статуса и их взаимосвязей у пациентов с лимфомами до начала противоопухолевой терапии

  • Open Access

    Assessment of Specific Biomarkers’ Profile and Structural, Functional Parameters of the Left Ventricle in Patients With Lymphomas Undergoing Antitumor Therapy

    by I. Ya. Sokolova, Sh. M. Murtuzaliev, S. A. Kardovskaya, A. A. Shchendrygina, P. A. Markin, S. A. Appolonova, T. Yu. Kulagina, O. A. Zhigulina, N. V. Khabarova, Yu. N. Belenkov, et al.

    Aim . To evaluate the dynamics of specific biomarkers for cardiotoxicity, endothelial dysfunction, fibrosis, systemic inflammation, and morpho-functional alterations in the left ventricular (LV) myocardium in patients with newly diagnosed lymphomas during 6 courses of polychemotherapy (PCT). Material and methods . The study included 30 patients with newly diagnosed lymphomas. All patients were evaluated for laboratory markers of cardiotoxicity at baseline and after 6 courses of chemotherapy (6 months), including N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin I (hsTnI), endothelin-1 (ET-1), circulating cardiac biomarker ST-2, high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and LV structural and functional echocardiographic (EchoCG) parameters. Results . The changes in NT-proBNP and hsTnI concentrations during 6 courses of PCT were not statistically significant. Comparison of the baseline values with those after 6 courses of PCT showed increases in the median concentrations of ET-1 (3.38 and 5.5 pg/ml, respectively; p=0.438) and ST-2 (12.21 and 26.75 ng/ml, respectively; p=0.687). Markers of systemic inflammation were significantly decreased after 6 courses of PCT: the median CRP decreased from 15.2 to 0.72 mg/ml (p=0.006), and the median IL-6 decreased from 12.2 to 5.1 pg/ml (p=0.034). EchoCG data revealed a statistically significant impairment of the LV diastolic function parameters (E/A; E/e’ lateral; E/e’ average; left atrial volume index; isovolumic relaxation time). A moderate direct correlation was found between the ET-1 concentration and the isovolumic relaxation time at baseline and after 6 courses of PCT, respectively (r1 = 0.387, p=0.047 and r2 = 0.391, p=0.035). No changes in the LV systolic function were observed. Conclusion . The study showed that patients with lymphoproliferative diseases had no signs of cardiotoxicity during PCT according to the accepted criteria. This study described and highlighted for the first time the interrelation of endothelial dysfunction, profibrotic status, and LV diastolic dysfunction as manifestations of cardiovascular toxicity in patients with lymphoproliferative diseases. It is advisable to supplement the integrated strategies for the prevention and monitoring of PCT cardiovascular toxicity with a thorough evaluation of instrumental parameters of diastolic dysfunction for timely initiation/correction of cardioprotective therapy.


  • Open Access

    Successful Implementation of Combined Treatment Methods for a Rare Recurrence of Waldenstrom Macroglobulinemia With Extramedullary Lesions

    by Irina Yakovlevna Sokolova, Sabina Maximovna Sokolova, Olga Valentinovna Bochkarnikova, Ayshat Eldarovna Rasulova, Timur Raisovich Izmailov, Pavel Vladimirovich Polushkin, Yulia Yurevna Kirichenko, Yuriy Nikitich Belenkov, Irina Sergeevna Ilgisonis

    Successful Implementation of Combined Treatment Methods for a Rare Recurrence of Waldenstrom Macroglobulinemia With Extramedullary Lesions

  • Open Access

    Difficulties in diagnosing intestinal T-cell lymphoma. Case report

    by I Y Gadaev, V I Ershov, A M Kovrigina, I Y Sokolova, O V Tashyan, M A Mingalimov, O N Antyufeeva, D A Budanova, M G Mnatsakanyan, O V Bochkarnikova, et al.

    The article describes a rare diagnosis of monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL), due to its veiled by a number of so-called masks of enteropathies. A detailed analysis of all clinical, morphological and immunohistochemical data made it possible to establish the correct diagnosis. The revealed pathology is extremely rare in practice, even among specialists in hematology. The article demonstrates the main stages of both a complex diagnosis and an attempt at therapy for this aggressive form of intestinal lymphoma.

  • Open Access

    Correlation between the level of C-reactive protein and the parameters of the functional status of the left atrium in patients with lymphoproliferative diseases against the background of chemotherapy

    by E. Yu. Salakheeva, A. A. Shchendrygina, I. Ya. Sokolova, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, Yu. N. Muzychenko, S. A. Kardanova, V. O. Stebakova, E. V. Privalova, et al.

    Aim. To assess the dynamics of functional changes in the left atrium (LA) in patients with lymphoproliferative diseases (LPD) before polychemotherapy (PCT), during treatment, after 6 courses of treatment, and the frequency of supraventricular arrhythmias (SVA) as well as the level of C-reactive protein. Material and methods. This is a prospective observational study of patients with confirmed diagnosis of lymphoma (n = 30; 57% men; median age 52 [34; 65] years old), who had no prior polychemotherapy. The comparison group included persons without lymphoma (n = 30; 49% men; median age 49 [36; 65] years old) comparable to the main group in terms of sex, age and risk factors for cardiovascular diseases. Patients with lymphoma underwent 24h-ECG monitoring and advanced transthoracic echocardiography with 2D speckle-tracking at baseline, and after 3 and 6 cycles (within 3 and 6 months) of anticancer treatment. Biomarkers of inflammation were measured. The results were compared to the data of the comparison group. Results. In lymphoma patients GLS LA, LA strain reservoir, LA strain conduit, and LA strain booster pump were found to be impaired at baseline but were comparable with these in matched controls. There was a significant decrease in GLS LA (LA strain reservoir 30% [26–41] vs 17% [15–31], p = 0.015) after 6 courses of PCT. In lymphoma patients before PCT, supraventricular tachycardia (SVT) was recorded significantly more often than in patients of the comparison group: 53% (n = 16) versus 20% (n = 6), (p = 0.02). The frequency of SVT was comparable in patients with LPD before and after 6 courses of chemotherapy: 53% (n = 16) vs 47% (n = 14) (p = 0 .7). Associations between the parameters of structural and functional changes in the LA and the incidence of SVA were not identified. A close correlation was found between the level of ESR, CRP and the parameters of the functional state of the LA. There was a significant relationship of the average strength between the ESR and the number of SVE in the analysis at all control points (rxy = 0.44, p < 0.05). Conclusions. In lymphoma patients LA dysfunction occurs, which progressively worsens against the background of antitumor therapy, and is associated with the severity of systemic inflammation that may be a manifestation of the cardiotoxic effect of PCT, but additional studies are required.


  • Open Access

    Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients

    by K. A. Zhbanov, E. Yu. Salakheeva, I. Ya. Sokolova, E. A. Zheleznykh, V. Yu. Zektser, E. V. Privalova, Yu. N. Belenkov, A. A. Shchendrygina

    Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients